![](https://tracker.live.rns-distribution.com/track.live-rns/5272625_d9353a075fe0b610698e373da828b7e4.png)
BAE Systems plc
TRANSACTION IN OWN SHARES
BAE Systems plc (the "Company") announces that, in accordance with the terms of its share repurchase programme announced on 28 July 2022 (the "Buyback Programme") and following the announcement on 1 June 2023 in relation to the initiation of the third tranche of the Buyback Programme (the "Third Tranche"), the Company purchased the following number of its ordinary shares of 2.5p each from Morgan Stanley & Co. International plc.
Date of purchase: | 18 July 2024 |
Number of ordinary shares purchased: | 156,591 |
Highest price paid per share (p): | 1,280.00 |
Lowest price paid per share (p): | 1,268.00 |
Volume weighted average price paid per share (p): | 1,275.85 |
The Company intends to cancel the purchased shares.
In relation to the Third Tranche, since 1 June 2023, BAE Systems plc has purchased 42,874,089 shares at a cost (including dealing and associated costs) of £494,813,240.64.
A full breakdown of the individual trades made by Morgan Stanley & Co. International plc on behalf of the Company as part of the share repurchase programme is attached to this document.
http://www.rns-pdf.londonstockexchange.com/rns/0137X_1-2024-7-18.pdf
This announcement does not constitute, or form part of, an offer or any solicitation of an offer for securities in any jurisdiction.
This announcement will also be available on the Company's website at: https://investors.baesystems.com/regulatory-news
For further information, please contact:
Investors | Media |
Martin Cooper, Investor Relations Director Telephone: +44 (0)1252 383455 Email: investors@baesystems.com | Kristina Anderson, Director, Media Relations Telephone: +44 (0) 7540 628673 |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.